Search for a full or partial Catalog Number, CAS Number or description
CAS Number: 1314-13-2
Product Catalog
30-1400
Nanomaterials › Zinc oxide nanopowder| CAS Number: | 1314-13-2 |
| MDL Number: | MFCD00011300 |
| Molecular Formula: | OZn |
| Molecular Weight: | 81.37 |
| Chemical Formula: | ZnO |
| Color and Form: | off-white pwdr. |
| Note: |
| SECTION 1: Product Identification | |
|---|---|
| Chemical Name: | Zinc oxide nanopowder |
| Product Number: | 30-1400 |
| CAS Registry Number: | 1314-13-2 |
| Formula: | ZnO |
| EINECS Number: | 215-222-5 |
| Chemical Family: | nano structured metal oxide |
| Synonym: | Zinc monoxide nanopowder |
| SECTION 2: Composition and Information on Ingredients | ||||
|---|---|---|---|---|
| Ingredient | CAS Number | Percent | ACGIH (TWA) | OSHA (PEL) |
| Title compound | 1314-13-2 | 100 | 10mg/m3 | 15mg/m3 |
| SECTION 3: Hazards Identification | |
|---|---|
| Emergency Overview: | Irritating to skin, eyes and respiratory tract. Inhalation of high levels may produce symptoms known as metal fume fever or zinc shakes. |
| Primary Routes of Exposure: | Ingestion, inhalation |
| Eye Contact: | Causes slight to mild irritation of the eyes. |
| Skin Contact: | Causes slight to mild irritation of the skin. |
| Inhalation: | Very fine powder. Do not breath dust. Irritating to the nose, mucous membranes and respiratory tract. |
| Ingestion: | No information available on the physiological effects of ingestion. Zinc salts have a harsh metallic taste. |
| Acute Health Effects: | Irritating to skin, eyes and respiratory tract. Inhalation of dust may cause chills, muscle aches, nausea, fever, dry throat, cough, headache, blurred vision, vomiting and decreased pulmonary function. |
| Chronic Health Effects: | Prolonged or repeated exposure may cause breathing difficulty and decreased pulmonary function. |
| NTP: | No |
| IARC: | No |
| OSHA: | No |
| SECTION 4: First Aid Measures | |
|---|---|
| Eye Exposure: | Immediately flush the eyes with copious amounts of water for at least 10-15 minutes. A victim may need assistance in keeping their eye lids open. Get immediate medical attention. |
| Skin Exposure: | Wash the affected area with water. Remove contaminated clothes if necessary. Seek medical assistance if irritation persists. |
| Inhalation: | Remove the victim to fresh air. Closely monitor the victim for signs of respiratory problems, such as difficulty in breathing, coughing, wheezing, or pain. In such cases seek immediate medical assistance. |
| Ingestion: | Seek medical attention immediately. Keep the victim calm. Give the victim water (only if conscious). Induce vomiting only if directed by medical personnel. |
| SECTION 5: Fire Fighting Measures | |
|---|---|
| Flash Point: | not applicable |
| Autoignition Temperature: | none |
| Explosion Limits: | none |
| Extinguishing Medium: | None. Material is non-flammable |
| Special Fire Fighting Procedures: | No special fire-fighting procedures. The material is non-flammable. |
| Hazardous Combustion and Decomposion Products: | No hazardous combustion or decomposition products. |
| Unusual Fire or Explosion Hazards: | No unusual fire or explosion hazards. |
| SECTION 6: Accidental Release Measures | |
|---|---|
| Spill and Leak Procedures: | Small spills can be mixed with vermiculite or sodium carbonate and swept up. |
| SECTION 7: Handling and Storage | |
|---|---|
| Handling and Storage: | Store in a tightly sealed container. |
| SECTION 8: Exposure Controls and Personal Protection | |
|---|---|
| Eye Protection: | Always wear approved safety glasses when handling a chemical substance in the laboratory. |
| Skin Protection: | Wear protective clothing and gloves. |
| Ventilation: | Material is a very fine powder. It must be handled in an efficient fume hood. |
| Respirator: | If ventilation is not available a respirator should be worn. The use of respirators requires a Respirator Protection Program to be in compliance with 29 CFR 1910.134. |
| Additional Protection: | No additional protection required. |
| SECTION 9: Physical and Chemical Properties | |
|---|---|
| Color and Form: | off-white powder |
| Molecular Weight: | 81.37 |
| Melting Point: | no data |
| Boiling Point: | no data |
| Vapor Pressure: | not applicable |
| Specific Gravity: | no data |
| Odor: | none |
| Solubility in Water: | insoluble |
| SECTION 10: Stability and Reactivity | |
|---|---|
| Stability: | air and moisture stable |
| Hazardous Polymerization: | no hazardous polymerization |
| Conditions to Avoid: | none |
| Incompatibility: | strong mineral acids and bases |
| Decomposition Products: | none |
| SECTION 11: Toxicological Information | |
|---|---|
| RTECS Data: | Administration onto the skin(rabbit); Standard Draize test: 500mg/24H. Oral(human); LDLo: 500mg/kg. Inhalation(human); TCLo: 600mg/m3. Oral(rat); LD: >8437mg/kg. Intraperitoneal(rat); LD50: 240mg/kg. Oral(mouse); LD50: 7950mg/kg. Inhalation(mouse); LC50: 2500mg/m3. Oral(rat); TDLo: 17431mg/kg/90D-C. Inhalation(guinea pig); TCLo: 5900ug/m3/3H/3D-I. Inhalation(guinea pig); TCLo: 4600ug/m3/3H/6D-I. Oral(chicken); TDLo: 32203mg/kg/4W-C. Oral(mammal-domestic); TDLo: 3584mg/kg/4W-I. Oral(rat); TDLo: 6846mg/kg. Inhalation(rat); Cytogenetic analysis: 100ug/m3. Hamster embryo; Morphological Transformation: 1mg/L. |
| Carcinogenic Effects: | no data |
| Mutagenic Effects: | no data |
| Tetratogenic Effects: | no data |
| SECTION 12: Ecological Information | |
|---|---|
| Ecological Information: | Very toxic to aquatic organisms |
| SECTION 13: Disposal Considerations | |
|---|---|
| Disposal: | Dispose of according to local, state and federal regulations. |
| SECTION 14: Transportation | |
|---|---|
| Shipping Name (CFR): | Non-hazardous |
| Hazard Class (CFR): | NA |
| Additional Hazard Class (CFR): | NA |
| Packaging Group (CFR): | NA |
| UN ID Number (CFR): | NA |
| Shipping Name (IATA): | Non-hazardous |
| Hazard Class (IATA): | NA |
| Additional Hazard Class (IATA): | NA |
| Packaging Group (IATA): | NA |
| UN ID Number (IATA): | NA |
| SECTION 15: Regulatory Information | |
|---|---|
| TSCA: | Listed in the TSCA inventory |
| SARA (Title 313): | Title compound: See Category Code N982 for reporting. |
| Second Ingredient: | none |
| Third Ingredient: | none |
| SECTION 16: Other Information | |
|---|---|
| Disclaimer: | The information herein is believed to be accurate and reliable as of the date compiled. However, Strem Chemicals, Inc. makes no representation, warranty, or guarantee of any kind with respect to the information contained in this document or any use of the product based on this information. |
| Preparation Date: | 5/07/2009 |
| Revision Date: | 12/27/2011 |
